Feasibility of using half‐dose Gd‐BOPTA for delayed gadolinium‐enhanced MRI of cartilage (dGEMRIC) at the knee, compared with standard‐dose Gd‐DTPA
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Magnetic Resonance Imaging"
DOI: 10.1002/jmri.26816
Abstract: We sought to replace full‐dose Gd‐DTPA with safer and lower‐dose contrast agents for delayed gadolinium‐enhanced MRI of cartilage (dGEMRIC). Gd‐BOPTA has a lower intrinsic nephrogenic systemic fibrosis risk and a 2‐fold higher relaxivity at 3T;… read more here.
Keywords: mri cartilage; gadolinium enhanced; delayed gadolinium; dose dtpa ... See more keywords